Tradestie Institutional Equity Comparison Engine

STRO vs PLUR โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

STRO Overall Edge

STRO Captures Institutional Edge (3โ€“1 Pillars ยท 6โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Sutro Biopharma, Inc. (STRO) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while PLUR counters with relative strength in Valuation. Fundamentally, STRO trades at 10.0x Forward P/E with -254.7% operating margin (-6.1% YoY revenue) versus PLUR at 3.6x Forward P/E and -2454.5% operating margin (-15.8% YoY). In options structure, STRO sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro) against PLUR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner PLUR
STRO 10.0x vs PLUR 3.6x Fwd P/E
Growth & Margin Winner STRO
Op Margin -254.7% vs -2454.5% ยท YoY -6.1% vs -15.8%
Momentum & Technical Winner STRO
1Y +883.6% vs -78.8% ยท 52W Pos 19% vs 2%
Options & Structure Winner STRO
UNCLASSIFIED (<1st %ile IV) vs UNCLASSIFIED (N/A IV)
STRO NASDAQ
Sutro Biopharma, Inc.
Biological Products, (No Diagnostic Substances)
$8.90
-4.51% 1D
Market Cap $163.0M
1M Return -20.92%
1Y Return +883.64%
Forward P/E 10.0x
Unified AI Score
45.1 / 100 HOLD
Tech 33.0 Fund 52.0 Flow 50.0 Mom 60.0
PLUR US Equity
Pluri Inc.
Biological Products, (No Diagnostic Substances)
$0.94
-9.19% 1D
Market Cap $15.1M
1M Return +11.09%
1Y Return -78.78%
Forward P/E 3.6x
Unified AI Score
28.8 / 100 SELL
Tech 15.0 Fund 34.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: STRO +883.64% PLUR -78.78% Spread: +959.17 pp (STRO Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
STRO TTM Op. Margin: -254.7% PLUR TTM Op. Margin: -2454.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on STRO vs PLUR. Trailing 12-month operating profitability (STRO -254.7% vs PLUR -2454.5%) and valuation multiples (STRO 10.0x vs PLUR 3.6x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: STRO (6) vs PLUR (3)
Institutional Metric STRO PLUR Criterion Row Winner
Market Capitalization Scale $163.0M $15.1M Larger Scale STRO
Trailing P/E Ratio Valuation 10.0x 3.6x Lower Multiple PLUR
Forward P/E Ratio Valuation 10.0x 3.6x Lower Multiple PLUR
Revenue Growth (YoY) Growth -6.1% -15.8% Higher Growth STRO
Operating Margin (TTM) Profitability -254.7% -2454.5% Higher Margin STRO
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -1810.0% -1022.0% Higher ROE PLUR
52-Week Range Position Momentum 19% ($1โ€“$44) 2% ($1โ€“$5) Stronger Trend STRO
Beta / 30D Volatility Risk Regime 1.65ฮฒ ยท 80% Vol 0.80ฮฒ ยท 102% Vol Lower Realized Risk STRO
Unified Institutional Score Composite Signal 45.1 / 100 (HOLD) 28.8 / 100 (SELL) Higher Composite STRO

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full STRO vs PLUR Buy Guide
STRO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live STRO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
PLUR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live PLUR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither STRO nor PLUR registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.